The cardiovascular version of Alzheimer’s may be a jackpot for a biotech
Surprise diagnoses have a method of constructing Ph.D. candidates out of on a regular basis individuals.
Walter Feigenson’s training started in 2007, at age 59, when he was wrongly identified with congestive coronary heart failure. Then got here carpal tunnel syndrome, which docs chalked as much as his years in entrance of a keyboard. In 2010 it was a ruptured bicep tendon, and in 2015 a case of a spinal situation known as lumbar stenosis. It wasn’t till 2018, when “dumb luck” landed Feigenson in entrance of a specialist at Oregon Well being and Science College, that somebody related the dots between his disparate signs: He had a progressive illness that was destroying his coronary heart.
Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!
GET STARTED
What’s it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, coverage, and life science protection and evaluation.
Our award-winning workforce covers information on Wall Avenue, coverage developments in Washington, early science breakthroughs and scientific trial outcomes, and well being care disruption in Silicon Valley and past.
What’s included?
- Day by day reporting and evaluation
- Probably the most complete trade protection from a powerhouse workforce of reporters
- Subscriber-only newsletters
- Day by day newsletters to temporary you on crucial trade information of the day
- STAT+ Conversations
- Weekly alternatives to interact with our reporters and main trade specialists in reside video conversations
- Unique trade occasions
- Premium entry to subscriber-only networking occasions across the nation
- The very best reporters within the trade
- Probably the most trusted and well-connected newsroom within the well being care trade
- And way more
- Unique interviews with trade leaders, profiles, and premium instruments, like our CRISPR Trackr.
